Consolidated Balance Sheets - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Prepaid expense	$ 1,500	$ 12,500
Marketable securities held in trust account – current	10,819,317
Total current assets	10,820,817	12,500
Noncurrent assets:
Marketable securities held in trust account	292,536	101,590,662
Total noncurrent assets	292,536	101,590,662
Total assets	11,113,353	101,603,162
Current liabilities:
Accrued expenses and other liability	350,213	220,401
Promissory notes and loan payable to Sponsor	394,488	5,755,961
Redemption liability	10,819,317
Total current liabilities	11,564,018	6,189,022
Noncurrent liabilities:
Deferred underwriting commissions	2,875,000	2,875,000
Total noncurrent liabilities	2,875,000	2,875,000
Total liabilities	14,439,018	9,064,022
Commitment and contingencies (Note 6)
Ordinary shares subject to possible redemption, 22,664 and 9,063,503 shares at redemption value of $12.91 and $11.21 per share at December 31, 2024 and 2023, respectively	292,536	101,605,662
Stockholders’ deficit:
Ordinary shares, par value $0.001, authorized 50,000,000 shares; 3,205,000 and 3,205,000 shares issued and outstanding at December 31, 2024 and 2023, respectively, excluding 22,664 and 9,063,503 shares subject to possible redemption	3,205	3,205
Additional paid-in capital	6,760,441
Accumulated deficit	(10,381,847)	(9,069,727)
Total stockholders’ deficit	(3,618,201)	(9,066,522)
Total liabilities and stockholders’ deficit	11,113,353	101,603,162
Sponsor [Member]
Current liabilities:
Due to Sponsor		$ 212,660